2025 HCPCS code S0132
Ganirelix Acetate, 250 mcg injection
Medical necessity for S0132 is established by the underlying diagnosis of infertility and the patient's participation in a medically necessary fertility treatment plan. The specific treatment protocol, including the use of S0132, should be documented.
Ganirelix acetate is used in fertility treatments. It blocks certain hormones to increase egg production and prevent premature release. It's administered as part of a controlled ovarian stimulation protocol.
In simple words: This is an injection of a medicine called ganirelix acetate, used in fertility treatments. It helps the body produce more eggs and prevents them from being released too early.
Injectable supply of 250 mcg of ganirelix acetate.
Example 1: A 35-year-old female undergoing in vitro fertilization (IVF) receives a daily dose of S0132 to prevent premature ovulation., A patient with unexplained infertility is prescribed S0132 injections during ovarian stimulation for timed intercourse., A woman undergoing controlled ovarian hyperstimulation for egg retrieval is given S0132 to regulate the timing of egg maturation and retrieval.
Documentation should include the diagnosis necessitating fertility treatment, the dosage and administration of ganirelix acetate, and monitoring results related to ovarian response.
** S-codes are temporary codes often used when a permanent HCPCS code hasn't been established. They may vary among payers, and it's always important to check with the specific payer for coverage policies.
- Payment Status: Not payable by Medicare
- Specialties:Reproductive Endocrinology, Infertility
- Place of Service:Office